Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24856183

New Drug Could Help Maintain Long-Term Weight Loss (news – 2012) http://www.sciencedaily.com/releases...0726122116.htm Peripherally restricted CB1 recepto...

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human (full - 2000) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full – 2002) http://bloodjournal.hematologylibrar...a7d081bcc2771d

Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors (abst - 2004) http://www.ncbi.nlm.nih.gov/pubmed/15556131 CB2 cannabinoid receptors in trabecul...

Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth (abst – 2014)http://pubs.acs.org/doi/abs/10.1021/mp5001923

Getting high on the endocannabinoid system. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/

Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/

Endocannabinoid Modulation of Cortical Up-States and NREM Sleep (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919802/

Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111603/

Antidepressants and Changes in Concentration of Endocannabinoids and Nacylethanolamines in Rat Brain Structures. (full – 2014) http://download.springer.com/static/...A10.1007%252Fs...

Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24856183

New Drug Could Help Maintain Long-Term Weight Loss (news – 2012) http://www.sciencedaily.com/releases...0726122116.htm Peripherally restricted CB1 recepto...

A novel synthetic, non-psychoactive cannabinoid acid (HU-320) with anti-inflammatory properties in murine collagen-induced arthritis (full - 2004 http://onlineli...

A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells (full - 2006)http://molpharm.aspetjournals.org/content/70/1/51.long A Cannabinoid Anticancer Quinone, HU-331, Is More Pot...

A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury...

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat (abst – 1993)http://www.ncbi.nlm.nih.gov/pubmed/8411215

HU-211, a Novel Noncompetitive N-Methyl-D-Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat (full - 1995) http://stroke.ahajournals.org/cgi...

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor (full – 1999) http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2005)http://www.fasebj.org/cgi/content/fu...EX=0&sortspec=...

The cannabinoids R(-)-7-hydroxy-delta-6-tetra-hydrocannabinol-dimethylheptyl (HU-210), 2-O-arachidonoylglycerylether (HU-310) and arachidonyl-2-chloroethylamide...

Intrathecal injection of a Cannabinoid CB2 Receptor Selective Agonist GW405833 Blocks Induction of Allodynia by Sciatic Inflammatory Neuritis (SIN) (abst – 2009) http://www.efic-congress.org/showabs...p?abstract=166 Paradoxical effects of ...

Hexahydrocannabinols, novel synthetic cannabinoid derivatives, suppress the tumor growth by inhibiting the VEGF secretion and angiogenesis (abst – 2009) http://www.fasebj.org/cgi/content/meeting_...